However, research on the cardiovascular effects of GIP is still relatively limited, and the similarities and synergistic effects between GIP and GLP-1 require further exploration ( 5.2 Prospective clinical trial progress and results of tirzepatide in the treatment of type 2 diabetes with cardiovascular disease Currently, two significant cardiovascular outcome trials for tirzepatide are underway (or have recently concluded), including SURPASS-CVOT and SUMMIT
Formulated with the absorption enhancer sodium N-(8-[2-hydroxybenzoyl]amino)caprylate (SNAC), oral semaglutide undergoes direct mucosal exposure in the stomach (52)
The CagriSema combination (cagrilintide plus semaglutide) has received more clinical attention, with Novo Nordisk advancing this combination through Phase 3 trials
Endocrinology 2000;141:46005.ArticlePubMed 62
Pharmaceutical versions of this hormone amplify these natural effects, which makes GLP-1 medications effective tools for managing type 2 diabetes and, at higher doses, for promoting weight loss